Association Between Serum Elabela Levels and Chronic Totally Occlusion in Patients with Stable Angina Pectoris

Fethi Yavuz1, Mehmet Kaplan2

  • 1Departamento de Cardiologia, Adıyaman University Training and Research Hospital, Adıyaman - Turquia.

Insights

Serum Elabela levels are lower in patients with chronic total occlusion (CTO) and correlate with poor collateral development. Lower Elabela indicates a higher risk of CTO and weaker collateral circulation.

Area of Science:

  • Cardiovascular Medicine
  • Biomarker Discovery
  • Interventional Cardiology

Background:

  • Elabela's beneficial cardiovascular effects are documented.
  • Chronic total occlusion (CTO) poses significant cardiovascular risks.
  • Collateral circulation is crucial for managing ischemic heart disease.

Purpose of the Study:

  • To compare serum Elabela levels in CTO patients versus controls.
  • To investigate the correlation between Elabela levels and collateral development in CTO patients.

Main Methods:

  • Cross-sectional and prospective study design.
  • Inclusion of 50 CTO patients and 50 control subjects with normal coronary arteries.
  • Measurement of serum Elabela, NT-proBNP, and troponin levels; assessment of collateral development using Rentrop classification.

Main Results:

  • Demographics and routine labs were similar between groups.
  • CTO patients exhibited lower mean Elabela levels but higher NT-proBNP and troponin compared to controls.
  • Elabela levels were independently predictive of CTO and positively correlated with good collateral development (Rentrop class 2-3).

Conclusions:

  • Reduced serum Elabela levels are associated with CTO.
  • Elabela levels correlate with the extent of coronary collateral development.
  • Elabela may serve as a potential biomarker for CTO and collateralization.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
62
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
72
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
104
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
84
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
207
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
126